Aethlon Medical, Inc.
AEMD
$1.18
-$0.02-1.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.66% | 21.97% | 3.11% | 7.33% | -1.48% |
| Total Depreciation and Amortization | -5.40% | -3.18% | 2.92% | 18.07% | 49.02% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 327.90% | -47.38% | 7.30% | -9.58% | 1.84% |
| Change in Net Operating Assets | -80.45% | -174.75% | 455.83% | 3.37% | 633.08% |
| Cash from Operations | 24.52% | 18.77% | 11.69% | 8.42% | 3.57% |
| Capital Expenditure | 100.00% | 97.24% | 96.58% | 98.19% | 73.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 97.24% | 96.58% | 98.19% | 73.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 498.25% | 327.01% | 417.50% | -40.17% | -85.19% |
| Repurchase of Common Stock | 45.69% | 23.18% | -12.33% | -50.72% | -178.40% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 500.14% | 335.52% | 426.15% | -40.37% | -85.56% |
| Foreign Exchange rate Adjustments | -710.00% | -611.76% | 197.26% | 114.52% | 133.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.77% | 66.97% | 64.82% | -89.00% | -257.99% |